These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 7967984)
21. Leprosy in Malawi. 2. Background, design and prospects of the Karonga Prevention Trial, a leprosy vaccine trial in northern Malawi. Fine PE; Ponnighaus JM Trans R Soc Trop Med Hyg; 1988; 82(6):810-7. PubMed ID: 3076995 [TBL] [Abstract][Full Text] [Related]
22. Rationales for vaccines against leprosy. Bloom BR Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):505-9. PubMed ID: 6368414 [No Abstract] [Full Text] [Related]
23. Relationships between titers of antibodies immunoreacting against glycolipid antigens from Mycobacterium leprae and M. tuberculosis, the Mitsuda and Mantoux reactions, and bacteriological loads: implications in the pathogenesis, epidemiology and serodiagnosis of leprosy and tuberculosis. David HL; Papa F; Cruaud P; Berlie HC; Maroja MF; Salem JI; Costa MF Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):208-24. PubMed ID: 1522363 [TBL] [Abstract][Full Text] [Related]
24. Comparative study of immunizing and delayed hypersensitivity eliciting antigens of Mycobacterium leprae, M. tuberculosis, M. vaccae, and M. bovis (BCG). Sinha S; Sreevatsa ; Gupta SK; Sengupta U Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):42-53. PubMed ID: 2435824 [TBL] [Abstract][Full Text] [Related]
25. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results. Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891 [TBL] [Abstract][Full Text] [Related]
26. Incidence rates of leprosy in Karonga District, northern Malawi: patterns by age, sex, BCG status and classification. Pönnighaus JM; Fine PE; Sterne JA; Bliss L; Wilson RJ; Malema SS; Kileta S Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):10-23. PubMed ID: 8189075 [TBL] [Abstract][Full Text] [Related]
27. Sensitization studies with potential leprosy vaccine preparations in northern Malawi. Ponnighaus JM; Fine PE Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):25-37. PubMed ID: 3519803 [TBL] [Abstract][Full Text] [Related]
28. How environmental mycobacteria may predetermine the protective efficacy of BCG. Stanford JL; Shield MJ; Rook GA Tubercle; 1981 Mar; 62(1):55-62. PubMed ID: 7268920 [TBL] [Abstract][Full Text] [Related]
29. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations. Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286 [TBL] [Abstract][Full Text] [Related]
30. Impairment of reactivity to lepromin by mycobacterial antigens related to, or identical with, Mycobacterium leprae. Kwapinski JB; Bechelli LM; Haddad N; Simao ET Can J Microbiol; 1975 Jun; 21(6):896-901. PubMed ID: 1097072 [TBL] [Abstract][Full Text] [Related]
31. Dissociation between allergy and immunity in mycobacterial infections. Turk JL Lepr Rev; 1983 Mar; 54(1):1-8. PubMed ID: 6341738 [No Abstract] [Full Text] [Related]
32. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations. Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067 [TBL] [Abstract][Full Text] [Related]
33. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae. De Britto RL; Ramanathan VD; Gupte MD Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749 [TBL] [Abstract][Full Text] [Related]
34. Leprosy and tuberculosis vaccine design. Kaufmann SH Trop Med Parasitol; 1989 Sep; 40(3):251-7. PubMed ID: 2482532 [TBL] [Abstract][Full Text] [Related]
35. Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application. Coppola M; van den Eeden SJF; Robbins N; Wilson L; Franken KLMC; Adams LB; Gillis TP; Ottenhoff THM; Geluk A Front Immunol; 2018; 9():308. PubMed ID: 29535713 [TBL] [Abstract][Full Text] [Related]
36. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results. Convit J; Sampson C; Zúñiga M; Smith PG; Plata J; Silva J; Molina J; Pinardi ME; Bloom BR; Salgado A Lancet; 1992 Feb; 339(8791):446-50. PubMed ID: 1346818 [TBL] [Abstract][Full Text] [Related]
37. Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guérin from infection with Mycobacterium tuberculosis. Roche PW; Triccas JA; Avery DT; Fifis T; Billman-Jacobe H; Britton WJ J Infect Dis; 1994 Nov; 170(5):1326-30. PubMed ID: 7963739 [TBL] [Abstract][Full Text] [Related]
38. Sensitivity to mycobacterial antigens. Damluji SF Bull World Health Organ; 1974; 51(3):279-82. PubMed ID: 4142757 [TBL] [Abstract][Full Text] [Related]
39. Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi. Black GF; Fine PEM ; Warndorff DK; Floyd S; Weir RE; Blackwell JM; Bliss L; Sichali L; Mwaungulu L; Chaguluka S; Jarman E; Ngwira B; Dockrell HM Int J Tuberc Lung Dis; 2001 Jul; 5(7):664-72. PubMed ID: 11467373 [TBL] [Abstract][Full Text] [Related]
40. Persistence and boosting of bacille Calmette-Guérin-induced delayed-type hypersensitivity. Hoft DF; Tennant JM Ann Intern Med; 1999 Jul; 131(1):32-6. PubMed ID: 10391813 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]